.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
QuintilesIMS
AstraZeneca
Accenture
McKesson
McKinsey
Merck
UBS
Medtronic
Teva

Generated: July 20, 2017

DrugPatentWatch Database Preview

DESIPRAMINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Desipramine Hydrochloride, and what generic Desipramine Hydrochloride alternatives are available?

Desipramine Hydrochloride is a drug marketed by Sandoz, Actavis Totowa, Ani Pharms Inc, Amneal Pharms Co, Heritage Pharms Inc, Impax Labs Inc, and Usl Pharma. and is included in nineteen NDAs.

The generic ingredient in DESIPRAMINE HYDROCHLORIDE is desipramine hydrochloride. There are nine drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the desipramine hydrochloride profile page.

Summary for Tradename: DESIPRAMINE HYDROCHLORIDE

Patents:0
Applicants:7
NDAs:19
Suppliers / Packagers: see list12
Bulk Api Vendors: see list37
Clinical Trials: see list2,298
Patent Applications: see list1,043
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DESIPRAMINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: DESIPRAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs Inc
DESIPRAMINE HYDROCHLORIDE
desipramine hydrochloride
TABLET;ORAL205153-006Oct 28, 2016ABRXNoNo► Subscribe► Subscribe
Impax Labs Inc
DESIPRAMINE HYDROCHLORIDE
desipramine hydrochloride
TABLET;ORAL205153-002Oct 28, 2016ABRXNoNo► Subscribe► Subscribe
Usl Pharma
DESIPRAMINE HYDROCHLORIDE
desipramine hydrochloride
TABLET;ORAL071864-001Sep 9, 1987DISCNNoNo► Subscribe► Subscribe
Impax Labs Inc
DESIPRAMINE HYDROCHLORIDE
desipramine hydrochloride
TABLET;ORAL205153-003Oct 28, 2016ABRXNoNo► Subscribe► Subscribe
Sandoz
DESIPRAMINE HYDROCHLORIDE
desipramine hydrochloride
TABLET;ORAL072100-001May 24, 1988ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Julphar
Accenture
Mallinckrodt
Cerilliant
Daiichi Sankyo
McKinsey
Dow
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot